SSI gets Nod to begin H1N1 Vaccine Trials
The Drugs Controller-General of India (DCGI) gave a go-ahead to the Serum Institute of India (SSI) to start human clinical trials of the intra-nasal spray developed to combat the spread of the lethal swine flu.
